Systemic anti-tumor necrosis factor antibody treatment exacerbates endotoxin-induced uveitis in the rat

This publication has 40 references indexed in Scilit:

• Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
  Arthritis & Rheumatism, 1993
• Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.
  The Journal of Experimental Medicine, 1993
• The Pathophysiology of Tumor Necrosis Factors
  Annual Review of Immunology, 1992
• Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortality
  Life Sciences, 1989
• Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivo
  Clinical Immunology and Immunopathology, 1989
• Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.
  The Journal of Experimental Medicine, 1989
• The Biology of Cachectin/TNF -- A Primary Mediator of the Host Response
  Annual Review of Immunology, 1989
• Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofylline
  Biochemical and Biophysical Research Communications, 1988
• Pentoxifylline
  Drugs, 1987
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976